Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany

Biologic drugs represent a large and growing portion of health expenditures. Increasing the use of biosimilars is a promising option for controlling spending growth in pharmaceutical care. Amid the considerable uncertainty concerning physicians’ decision to prescribe biosimilars, explicit cost contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Blankart, Katharina E., Arndt, Friederike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313006/
https://www.ncbi.nlm.nih.gov/pubmed/32526943
http://dx.doi.org/10.3390/ijerph17114113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313006/
https://www.ncbi.nlm.nih.gov/pubmed/32526943
http://dx.doi.org/10.3390/ijerph17114113

Ejemplares similares